| OTC Markets: VPRO
Viropro, Inc. is a biopharmaceutical company, which is specialized in contract research, development and manufacturing of bio-therapeutic proteins for the treatment of various diseases, including cancer, diabetes, hepatitis and multiple sclerosis. The company operates through its subsidiaries: Viropro International, Inc., Biologics Process Development, Inc., Alpha Biologics Ltd. and Alpha Biologics Sdn. Bhd. The Viropro International subsidiary focuses on microbiology and handles cloning and sequencing as part of its integrated services from clone to production. The Biologics Process Development, Inc. subsidiary provides contract laboratory services for the biotechnology and biopharma industries. The Alpha Biologics Ltd. subsidiary provides contract biomanufacturing services. It supplies of mammalian cell proteins for pre-clinical, clinical trial or final market use. The Alpha Biologics Sdn. Bhd. subsidiary provides clinical manufacturing services. The company was founded on June 16, 1982 and is headquartered in Irvine, CA.